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The innate immune system detects viral infection primarily by recognizing viral nucleic acids inside an infected cell 1 . In the case of retroviruses, which are RNA viruses that replicate via a DNA intermediate, genomic RNA can be recognized in endosomes of specialized innate immune cells using Toll-like receptor 7 (TLR7) 2 , whereas the reverse-transcribed DNA is believed to be recognized during entry into a host cell by a cytoplasmic DNA sensor (or sensors) that triggers type I interferon production 3 . This latter response has been observed in cells that lack the endoplasmic reticulum (ER)-associated 3′ to 5′ exonuclease, TREX1. When TREX1 is present, it can degrade the viral DNA before sensing occurs.
Self DNA from the host cell seems to have a similar fate: a deficiency in Trex1 leads to the accumulation of endogenous retroelements and genomic DNA in the cytoplasm, causing aberrant activation of the DNA-sensing pathway and subsequent initiation of autoimmunity 4, 5 . Indeed, mutations in TREX1 are associated with human autoimmune disorders such as Aicardi-Goutières syndrome (AGS) 6 , familial chilblain lupus 7 and systemic lupus erythematosus (SLE) 6 . Genetic ablation of DNA-sensing pathway components (Irf3 or Tmem173 (also known as Sting)) or the type I interferon receptor can prevent disease onset in Trex1 -/-mice (an animal model of AGS) 4, 5 , demonstrating the key epistatic relationship between Trex1 and the interferon-stimulatory DNA (ISD)-sensing pathway, and linking the recognition of DNA viral and retroviral infection to the initiation of autoimmune disease. Identifying components of this pathway may facilitate the identification of therapeutics that modulate the DNA-sensing response to mitigate disease.
How cytosolic DNA elicits production of type I interferons is a long-standing question 8 that has gained key insights recently. Specific DNA sequences, for example, (A+T)-rich DNA, are recognized by cytosolic RNA polymerase III, which transcribes the DNA ligand into an RNA product that is recognized by the cytosolic RNA-sensing receptor RIG-I [9] [10] [11] . The innate immune recognition of retroviruses, retroelements and other non-(A+T)-rich DNA does not involve RNA polymerase III or RIG-I 3,5,12,13 but involves several of the downstream components of the RIG-I pathway. Recognition of cytosolic DNA relies on the intracellular transmembrane protein, STING 14, 15 , which binds to the kinase TBK1 and the transcription factor IRF3 to allow IRF3 phosphorylation 16 . Phosphorylated IRF3 then dimerizes and translocates into the nucleus to induce Ifnb1 expression. In addition, certain HMGB family proteins as well as the AIM2-like receptor, IFI16, are believed to have at least a partial role in the cytosolic DNA response 17, 18 . However, the underlying mechanisms remain poorly understood.
We describe here an integrative approach for identification of new components of this DNA-sensing pathway (referred to as the 'ISD-sensing pathway' here) and the innate immune response to retroviral infection. We combined unbiased quantitative proteomics with curation of candidates from existing proteomic, genomic Identification of regulators of the innate immune response to cytosolic DNA and retroviral infection by an integrative approach 1 8 0 VOLUME 14 NUMBER 2 FEBRUARY 2013 nature immunology r e s o u r c e and domain-based data sets, and functionally tested 809 of these candidates by high-throughput loss-of-function (RNA interference; RNAi) screening. We then validated hits by chemical inhibition, cDNA rescue or targeted knockout, and mined existing protein-protein interaction data sets (host-host and host-viral) to form a network model of the ISD-sensing pathway.
RESULTS

Quantitative proteomics identifies candidate pathway components
We generated 809 candidate genes from proteomic, genomic and domain-based data sets that we hypothesized contain unidentified ISD-sensing pathway components (Fig. 1a) . First, we used proteinprotein interaction data sets to nominate 36 candidate proteins that interacted with the known DNA-sensing signaling proteins STING 14, 15 , TBK1 (refs. 13,16), IKKε 13 and IRF3 (ref. 12) from a recent mass spectrometry study 19 as well as 99 candidates from our own mass spectrometry-based list of putative STING-interacting proteins (Supplementary Table 1 ). Second, we selected 321 DNAstimulated genes and interferon-stimulated genes (ISGs) from our own and existing microarray data sets (Online Methods) based on the hypothesis that a subset of components of this pathway are feedbackregulated 17, 20 . Third, we focused on 126 annotated phosphatases (Gene Ontology (GO): 0004721) and 71 deubiquitinases (GO: 0004221 and ref. 21) as part of our pilot screen to identify regulators of the ISD-sensing pathway 16, 20 .
Because there was no existing data set of cytoplasmic DNAinteracting proteins, we used quantitative proteomics to discover such proteins. We prepared cytoplasmic extracts from mouse embryonic fibroblasts (MEFs; Supplementary Fig. 1a ) and added biotinylated 45-base-pair double-stranded DNA ('ISD sequence' 12 ) coupled to streptavidin beads as bait. We used three-state stable isotope labeling by amino acids in cell culture (SILAC) to label and quantify proteins using mass spectrometry 22 , with 'medium' molecular weight (M) isotope-labeled cells used as negative control (lysates incubated with beads alone), 'light' (L) isotope-labeled cells for bead-DNA precipitation and 'heavy' (H) isotope-labeled cells for bead-DNA precipitation preceded by IFN-β stimulation to upregulate pathway components (Supplementary Fig. 1b) .
Although only a handful of bands were visually distinguishable by protein electrophoresis (Supplementary Fig. 1c,d) , we identified 184 proteins with SILAC ratios that exhibited enrichment for DNA binding after mass spectrometry (Fig. 1b, Supplementary Table 2 and Supplementary Fig. 1e ). Among the 184 proteins, 121 (64.2%) were classified by Gene Ontology as having nucleic acid binding function (P = 5.95 × 10 −58 ; GO: 0003676), and others were components of DNA-binding complexes.
Twenty of the 184 identified proteins (10.9%) represent the majority of known proteins involved in the immune sensing of cytosolic DNA (Fig. 1c) . We identified known components of DNA-sensing pathways including HMGB family proteins (HMGB1, HMGB2 and HMGB3) 18 , components of the AIM2 inflammasome (IFI202B and the HMGB proteins) 18, 23 and the cytosolic RNA polymerase III complex (POLR3A, POLR3B, POLR3C, POLR3D, POLR3E, POLR3F, POLR3G, POLR3H, POLR1C, POLR1D, POLR2E, POLR2H and CRCP). We also identified three members of the SET complex (TREX1, APEX1 and HMGB2) that regulate the ISD-sensing pathway as well as HIV-1 detection and infection 3, 4, 18, 24 . In addition, we identified the proteins SAMHD1 and TREX1 (refs. 25,26) , which are involved in regulating retroviral and retroelement detection and are responsible for AGS 4, 27 . These results validate the utility of quantitative mass spectrometry for finding components of cytosolic DNA-sensing pathways.
RNAi screen defines components of the ISD-sensing pathway To functionally test the 809 proteomic, genomic and domain-based candidate genes described above (Fig. 1a) , we developed a robust high-throughput screening assay, in which we knocked down genes with small interfering RNAs (siRNAs) in MEFs transfected with dsDNA and measured production of the interferon-inducible protein CXCL10 by enzyme-linked immunosorbent assay (ELISA; Supplementary Fig. 2a,b) . We used CXCL10 as a readout for interferon-inducible genes because of its high induction in response to nucleic acids, its dependence on IRF3 and the availability of robust Fig. 2c ). The siRNA screen ( Fig. 2a and Supplementary Table 3a-e) identified 15 genes that, upon their knockdown, led to over 90% less CXCL10 production in response to ISD stimulation, including DNA interactors (for example, Abcf1 and Reep4) and protein-protein interactors (for example, Cdc37 and Wdr77); and five genes for which CXCL10 was upregulated more than fourfold after knockdown, including phosphatases (for example, Ppp6c and Mdp1), deubiquitinases (for example, Usp12 and Cyld) and regulated genes (for example, Tiparp). We investigated several of the siRNA screening hits in detail (see below).
Several cytoplasmic DNA-interacting mass spectrometry hits had functional phenotypes in the siRNA screen (Supplementary Table 3a) . HMGB2 regulates nucleic acid-sensing pathways (ref. 18 and Supplementary Fig. 3a ) and interacts with DNA. ABCF1 is a cytosolic and ER-localized member of the ATP-binding cassette (ABC) family of transporters with a role in translational control 29 , but unlike other members of the ABC family, the Abcf subfamily proteins lack transmembrane domains. Although a role in DNA sensing had not been previously observed for ABCF1, there is evidence that human polyomavirus 6 and 7 proteins interact with ABCF1 (ref. 30 and Fig. 2b) . We used 14 different siRNAs targeting Abcf1 to interfere with Abcf1 mRNA expression in MEFs and measured by ELISA the induction of CXCL10 in response to stimulation of the ISD-sensing pathway. Knockdown of Abcf1 correlated with loss of CXCL10 induction (R 2 = 0.62), with three different siRNA screening pools (si-0, si-1 and si-2) that inhibited both Abcf1 mRNA and ABCF1 protein expression and CXCL10 induction most strongly (Fig. 3a) . Knockdown of Abcf1 with the strongest Abcf1 siRNA (si-1) resulted in >93% less production of CXCL10 (Fig. 3b) . Expression of an siRNA-resistant cDNA (Abcf1 rescue gene), but not of a Renilla luciferase cDNA control, significantly rescued this phenotype in a manner dependent on the amount of doxycycline used to titrate cDNA expression ( Fig. 3b  and Supplementary Fig. 3b,c) .
Known components of the ISD-sensing pathway such as Sting, Tbk1 and Irf3 represented strong hits in our siRNA screen (Fig. 2a) . Knockdown of each of these genes resulted in over 90% less CXCL10 production in response to stimulation with ISD (Supplementary (Fig. 2a,b and Supplementary Table 3c ). siRNA-mediated knockdown of Cdc37 resulted in over 96% less CXCL10 production in response to stimulation with ISD, which is comparable to the reduction induced by knockdown of Sting, Tbk1 or Irf3 (Supplementary Table 3c) . In addition, treatment of primary mouse lung fibroblasts or human monocytederived dendritic cells (MoDCs) with celastrol, a small molecule inhibitor of the CDC37-HSP90 interaction 31, 32 , potently decreased Ifnb1 and CXCL10 induction in cells stimulated with ISD ( Fig. 4a and  Supplementary Fig. 4a ). CDC37 is a molecular co-chaperone that (Fig. 4b) . In addition, siRNA-mediated knockdown of Cdc37 in MEFs abrogated phosphorylation of IRF3 at Ser396, a modification known to occur during activation of the ISD-sensing pathway (Fig. 4b) . Chemical inhibition of HSP90 (by 17-DMAG) or of TBK1 (by BX795) decreased production of ISD-stimulated Ifnb1 and CXCL10 in mouse lung fibroblasts and human MoDCs, similar to the decreases in the amounts of these cytokines caused by CDC37 inhibition (Fig. 4a and  Supplementary Fig. 4a) . Thus, targeting the members of this complex (Fig. 2b) with small molecules blocked the ISD-sensing response by potently inhibiting TBK1 protein stability or activity.
Secondary signaling downstream of the interferon receptor is also important in the ISD-sensing response (Fig. 2b) , and we identified known (for example, Irf9 and Stat1) and candidate mediators (for example, Ptpn1; ref. 34) of the secondary signaling network (Fig. 2b,  Supplementary Fig. 4b and Supplementary Table 3b,d) . MEFs deficient in the protein tyrosine phosphatase Ptpn1 produced 2.4-fold more CXCL10 in response to stimulation with ISD than rescued MEFs did ( Fig. 4c and Supplementary Fig. 4c ). Consistent with this result, small molecule inhibition of PTPN1 increased CXCL10 production 9.1-fold in human MoDCs stimulated with ISD (Fig. 4d) .
We also tested siRNA screening hits with unknown molecular interaction partners in the ISD-sensing pathway. SP110 is an interferonregulated nuclear body protein. (Supplementary Fig. 4d ). The serine-threonine phosphatase PPP6C has been proposed to interact with IκB-ε 33 , but its target in the ISD-sensing pathway is unknown. Consistent with the increased CXCL10 production we observed in the siRNA screen, we found that small molecule inhibition of PPP6C by okadaic acid increased ISD-stimulated CXCL10 production in human MoDCs 2.6-fold (Fig. 4d) . Taken together, our experiments identified regulators of the ISD-sensing pathway with roles in DNA sensing, primary signaling and secondary signaling.
ABCF1 interacts with HMGB2, IFI204 and the SET complex
Because the role of ABCF1 in DNA sensing has not been established previously, we investigated the interaction partners of ABCF1. In an unbiased quantitative mass spectrometry-based approach (Supplementary Fig. 5a ), we identified 53 proteins that significantly (P < 0.01) precipitated with hemagglutinin epitope-tagged ABCF1 (ABCF1-HA) in MEFs ( Fig. 5a and Supplementary Table 4) . Three of these proteins, SET, HMGB2 and ANP32A, are members of the ER-associated SET complex (Fig. 5a,b and Supplementary Fig. 5b ) that also contains the DNA exonucleases TREX1 and APEX1, which we identified in ISD interaction experiments (Fig. 1b,c) . None of these proteins were found upon pull-down of hemagglutinin epitope-tagged STING protein (STING-HA; Supplementary Table 1), indicating specificity for ABCF1. By immunofluorescence staining of MEFs stably expressing ABCF1-HA, we found that a subset of ABCF1 localized npg r e s o u r c e with SET and the ER marker calreticulin (Fig. 5c and Supplementary  Fig. 5c ), consistent with previous reports that ABCF1 localizes to both ER and cytosolic compartments 29 . These results suggest that ABCF1 interacts with the SET complex at the ER.
In addition to its role in the SET complex, HMGB2 is thought to function as a co-ligand for nucleic acid sensors, though its precise role remains unclear 18 . In our mass spectrometry analysis of ABCF1-HA-interacting proteins (Fig. 5a) , we found that ABCF1 interacted with HMGB2 as well as IFI204 (Fig. 5a,b) , whose related human protein, IFI16, is a putative DNA sensor 17 . Consistent with the reported functions of Hmgb2 and Ifi16 (refs. 17,18) , siRNA-mediated knockdown of Abcf1 suppressed TBK1 and IRF3 phosphorylation in MEFs stimulated with ISD ( Fig. 5d and Supplementary Fig. 5d,e) . siRNA-mediated knockdown of Abcf1 also significantly decreased 
Ifnb1 and ISG induction in MEFs after stimulation with dsDNA (HIV gag-100 sequence) or infection with HSV-1 d109 (Fig. 5e,f and Supplementary Fig. 5f,g ) but had no significant effect on Ifnb1 or ISG induction by Sendai virus (which stimulates the RIG-I pathway) or by recombinant IFN-β (Fig. 5f,g ). Taken together, these results suggest that ABCF1 interacts with HMGB2 and IFI204 and is a critical node in the DNA-sensing network (Supplementary Fig. 5b ).
Identified factors regulate host responses to retrovirus
We further examined whether the ISD-sensing pathway regulators described above also regulate the innate immune response to retroviral infection. Infection by an HIV-based retrovirus induced type I interferon and ISG production in Trex1 -/-MEFs but not in wild-type MEFs (ref. 3 and Supplementary Fig. 6a) . Knockdown of four of the genes identified in our siRNA screen (Ptpn1, Tiparp, Mdp1 and Ppp6c) in Trex1 -/-MEFs followed by infection with an HIV-based retrovirus significantly enhanced the ability of the retroviral infection to induce Ifnb1 and ISG production, whereas knockdown of ten of these genes (Asb13, Abcf1, Usp49, Reep4, Cyb5r3, Numa1, Wdr77, Asf1a, Mtmr3 and Cdc37) as well as of four known signal transduction components (Trim56, Sting, Tbk1 and Irf3) significantly abrogated the innate immune response (Fig. 6a-c and Supplementary Fig. 6b ).
Chemical inhibition of CDC37, HSP90 or TBK1 potently abrogated retroviral infection−induced Ifnb1 induction in Trex1 -/-MEFs (Fig. 6d,e and Supplementary Fig. 6c) ; in contrast, chemical inhibition of PTPN1 or PPP6C increased ISG induction in response to retroviral infection in a dose-dependent manner ( Fig. 6e and  Supplementary Fig. 6c ). We also tested several of these small molecules in human fibroblasts derived from two healthy individuals and from two patients with AGS that carry mutations in TREX1 (AGS patient 1 had an R114H substitution on one allele and an Asp201 insertion on the other allele, named 'R114H,D201ins' , and AGS patient 2 had homozygous mutations that encoded proteins with R114H substitutions, called 'R114H,R114H') 25 . The R114H variant is the most common mutation found in individuals with AGS and is also found in individuals with SLE 6 . Small-molecule targeting of CDC37 (celastrol), HSP90 (17-DMAG) and TBK1 (BX795) abrogated the induction of ISGs in the AGS fibroblasts ( Fig. 6f and Supplementary Fig. 6d ). Taken together, these results suggest that genetic or chemical inhibition of ISD-sensing pathway regulators we identified can modulate the innate immune response to retroviral infection in Trex1 -/-MEFs and in fibroblasts from patients with AGS.
DISCUSSION
We described here the integration of complementary genomic and proteomic data sets to identify new components and physical interactions in the ISD-sensing signaling network. We generated and used DNA-protein interaction, protein-protein interaction and loss-offunction screening data sets to identify new ISD-sensing pathway components; validated several of the newly identified components, including Abcf1; demonstrated that a subset of these newly identified components have functional roles in the response to retroviral infection in Trex1 -/-MEFs; and showed that small-molecule inhibitors of several of these components can modulate the innate immune response to dsDNA and retroviral infection in both mouse and human cells.
We identified SET complex members (SET, ANP32A and HMGB2) as interacting partners for ABCF1. The SET complex contains three DNA nucleases (TREX1, APEX1 and NME1), the chromatinmodifying proteins SET and ANP32A, and HMGB2, which functions as a co-receptor for nucleic acid receptors among other roles 36 . The observed interactions (whether direct or indirect) among dsDNA, ABCF1, HMGB2 and other SET complex members suggest that early steps in DNA recognition may occur at the ER-localized SET complex. Consistent with this hypothesis, the complex member TREX1 can prevent HIV-1 DNA detection, and its absence results in accumulation of retroelement DNA at the ER which drives an ISD-sensing response 3, 4, 37 . Furthermore, the complex members SET and NME1 also detect HIV-1 DNA and in turn regulate HIV-1 infectivity 27 . A recent model suggests that the SET complex may recognize viral DNA as damaged DNA, specifically via its base excision repair (BER) activity and/or its distorted structure (for example, HMGB2) 38 . Consistent with this model, the DNA interactors we identified included the SET and BER complex member APEX1 as well as nearly the entire BER complex (for example, PARP1, PARP2, POLB, LIG3, XRCC1, FEN1 and PCNA). Overall, these results suggest that the SET complex has a central role in DNA sensing and forms a coordinated system for detecting, modifying and degrading viral or retroelement DNA.
We also tested the impact of small-molecule inhibitors on the DNA-sensing response and found that inhibition of five components modulates the innate immune response to cytosolic DNA in human dendritic cells and to retroviral infection in TREX1 mutant fibroblasts. Targeting the two inhibitory phosphatases PTPN1 and PPP6C may serve as a way to enhance the immune response to DNA viruses and retroviruses or the immunogenicity of DNA vaccines 15, 39 . In contrast, inhibition of CDC37, HSP90 or TBK1 may be useful in treating certain autoimmune conditions. Several of these small molecules have already been tested for other conditions in mice and humans. For example, 17-DMAG is being explored for the treatment of autoimmune disease and various cancers 40 , and extracts of the medicinal plant Tripterygium wilfordii, from which the natural product celastrol is derived, have been used as an anti-inflammatory 41 . Although current treatments for TREX1-dependent autoimmune disorders (including AGS, familial chilblain lupus and SLE) do not target the cause of these diseases, small molecules such as celastrol, 17-DMAG and BX795 that inhibit the ISD-sensing response may represent new therapeutics for this class of disorders.
Several concrete results and new lines of investigation have emerged from the integrative approach described here. First, the proteomic and functional RNA interference data sets provide a resource for immunologists to mine and identify factors involved in any aspect of the cellular response to cytosolic DNA. Second, the finding that ABCF1 interacts with the SET complex and other critical factors opens up a new direction for studies of the ISD-sensing pathway, focusing on the hypothesis that DNA degradation and sensing are coordinated. Finally, our list of putative factors provides a large target space for seeking small-molecule inhibitors, leading us to identify several compounds with potential utility in treating patients with an overactive ISD-sensing pathway, as observed for AGS and related disorders.
METHODS
Methods and any associated references are available in the online version of the paper. 
